| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 10/14/2004 | WO2004087686A2 Benzopyran compounds useful for treating inflammatory conditions |
| 10/14/2004 | US20040204480 Anti-cancer combinations |
| 10/14/2004 | US20040202624 Galenical formulation |
| 10/14/2004 | DE10106024B4 Verfahren zur Herstellung von Dronabinol Process for preparing dronabinol |
| 10/14/2004 | CA2520724A1 Benzopyran compounds useful for treating inflammatory conditions |
| 10/14/2004 | CA2519291A1 Chromene derivatives as anti-inflammatory agents |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/13/2004 | EP1466891A1 Carboxylic acid derivative |
| 10/13/2004 | EP1466625A1 Preventives/remedies for urinary disturbance |
| 10/13/2004 | EP1466609A1 Method of preparing and using isoflavones |
| 10/13/2004 | EP1465968A2 Methods for treating deodorizer distillate |
| 10/13/2004 | EP1124817B1 Method of preparing delta-9-tetrahydrocannabinol esters |
| 10/13/2004 | EP0853647B1 Fluorinated xanthene derivatives |
| 10/13/2004 | CN1537169A Flavonid concentrates |
| 10/13/2004 | CN1537108A Iodobenzopyrran-4-one derivatives having fungicidal activity |
| 10/13/2004 | CN1535956A Substituted phenyl keto-enol pesticide and weedicide |
| 10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
| 10/13/2004 | CN1170528C Utilization of inhibitors of KQT1 channel in order to produce medicament for treating diseases which are caused by parasitic helminths and actoparasites |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | US6803381 Carbamic acid derivatives |
| 10/12/2004 | US6803129 Organic light emitting diode and organic luminescent materials thereof |
| 10/12/2004 | CA2300097C Liver function test |
| 10/07/2004 | WO2004085568A2 Photochromic articles with reduced temperature dependency and methods for preparation |
| 10/07/2004 | WO2004085418A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 10/07/2004 | WO2004084890A1 Therapeutic and prophylactic compositions and uses therefor |
| 10/07/2004 | US20040198750 Compositions useful as inhibitors of protein kinases |
| 10/07/2004 | US20040197404 Extended release oral dosage form |
| 10/07/2004 | DE10313700A1 New fluorinated oxa-anthracene compounds are useful in liquid crystal mixtures having a high dielectric anisotropy and high thermal, UV and light stability |
| 10/06/2004 | EP1463820A1 Method of screening compounds |
| 10/06/2004 | EP1463726A2 Aromatic thioether liver x-receptor modulators |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463495A2 Agents and methods for treatment of cancer |
| 10/06/2004 | EP1463487A1 Liposomal delivery of vitamin e based compounds |
| 10/06/2004 | EP1194424B1 Photochromic pyran derivatives |
| 10/06/2004 | CN1535269A Method for treating product stream containing vitamin E acetate |
| 10/06/2004 | CN1534034A Method of high effect preparing tea polyphenol |
| 10/06/2004 | CN1169820C Puerarin preparing process |
| 10/06/2004 | CN1169805C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 10/06/2004 | CN1169804C Extraction agent used for extracting proanthocyanidin from plants and extracting method |
| 10/05/2004 | US6800768 Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents |
| 10/05/2004 | US6800765 Fluorescent pH indicators for intracellular assays |
| 10/05/2004 | US6800657 Treating disorder responsive to positive modulation of ampa receptors in animals |
| 10/05/2004 | US6800433 Has antitumor, anti-inflammatory, anti-aging, antioxidant. antiallergy, antibacterial, and hair growth activities, and can be applied to foods, cosmetics, or drugs; solvent extraction |
| 10/05/2004 | CA2154605C Process for the preparation of .alpha.-tocopherol |
| 09/30/2004 | WO2004083209A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083204A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | US20040192762 Total synthesis of daurichromenic acid |
| 09/30/2004 | US20040192723 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
| 09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192672 Iodobenzopyran-4-one derivatives having fungicidal activity |
| 09/30/2004 | US20040191520 comprises 3-(4-methoxyphenyl)-3-phenyl-6,7,10,11-tetramethoxy-13-ethyl-13-hydroxy-13H-3H-indeno[2,'3,'3,4]naphtho[1,2-b]pyran; for activation via actinic radiation; improved optical density response; ophthalmic lens |
| 09/30/2004 | US20040191336 Process for producing high purity isoflavones |
| 09/30/2004 | CA2519442A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2517446A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 09/29/2004 | EP1462448A1 Process for preparing substituted coumarins |
| 09/29/2004 | EP1461330A1 3h-naphtho 2,1-b]-pyrane derivatives and the use of the same |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1460999A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 09/29/2004 | EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 09/29/2004 | EP1169304B1 8-8, 6-6 and 6-8 catechin and epicatechin dimers and methods for their preparation |
| 09/29/2004 | EP1076653B1 Novel cannabinoids selective for the cb2 receptor |
| 09/29/2004 | EP1067965B1 Pharmaceutical composition for treating cerebral apoplexy and craniocerebral trauma |
| 09/29/2004 | EP0815857B1 Antiobestic agent containing procyanidin as the active ingredient |
| 09/29/2004 | CN1533406A Photoactive materials |
| 09/28/2004 | US6797838 Process for preparing homophthalate derivatives |
| 09/28/2004 | US6797819 Alkaloids |
| 09/28/2004 | US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 09/28/2004 | US6797714 Hypoglycemic agents; antidiabetic agents; side effect reduction |
| 09/23/2004 | WO2004080995A1 Process for producing proanthocyanin-rich material |
| 09/23/2004 | WO2004080994A1 Process for producing proanthocyanidin enriched product |
| 09/23/2004 | WO2004080993A1 Process for producing proanthocyanidin-rich material |
| 09/23/2004 | WO2004080992A1 Process for producing proanthocyanin-rich material |
| 09/23/2004 | WO2004080991A1 Novel crystal of n-[3-(formylamino)-4-oxo-6-phenoxy-4h-cromene-7-yl]methanesulfonamide |
| 09/23/2004 | US20040186167 synthesizing EGCG-amides; useful for treating prostate cancer, leukemia, hormone dependent cancers, breast, colon, lung, epidermal, liver, esophageal, stomach, brain, and kidney cancer |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186132 Steroid receptor modulator compounds and methods |
| 09/23/2004 | US20040182692 Method for treating a product stream containing vitamin e acetate |
| 09/23/2004 | CA2517668A1 Process for producing proanthocyanin-rich material |
| 09/22/2004 | EP1460073A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1458724A1 Total synthesis of galanthamine, analogues and derivatives thereof |
| 09/22/2004 | EP1458703A1 Isochroman compounds for treatment of cns disorders |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1165694B1 4,7-dichlororhodamine dyes useful as molecular probes |
| 09/22/2004 | EP1100520B1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 09/22/2004 | EP1060266A4 Method for identifying mismatch repair glycosylase reactive sites, compound and uses thereof |
| 09/22/2004 | CN1531724A Optical data carrier containing heterocyclic azy dye as light-absorbing compound in information layer |
| 09/22/2004 | CN1530363A Method of extracting terpene lactone from folium ginkgo leaves and product |
| 09/22/2004 | CN1167697C Benzopyran derivative |
| 09/22/2004 | CN1167418C Use of nebivolol as anti-atherogenic |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794375 Palatable arginine compounds and uses thereof for cardiovascular health |
| 09/21/2004 | CA2256718C Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| 09/16/2004 | WO2004078988A1 Process for production of aromatic diols |
| 09/16/2004 | WO2004078741A1 Adiponectin expression promoter |
| 09/16/2004 | US20040181826 for for producing flavonoids using transgenic plants transformed by a genetically engineered vector |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |